Brain Stimulation and Cognitive Training for MCI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60-85
SponsorMedical University of South Carolina

About this trial

This is a randomized clinical trial of a treatment that combines non-invasive brain stimulation with computerized cognitive training (CCT) for people with mild cognitive impairment (MCI). The form of brain stimulation used in this study is accelerated intermittent theta burst stimulation (iTBS). All participants receive the same amount of iTBS and are randomly assigned to engage in one of two types of CCT. The goals of the study are to see if this combined treatment is feasible and acceptable to people with MCI and whether combined iTBS and CCT improves memory, thinking skills, mood, and daily function.

Eligibility criteria

Qualifiers

Age 60-85 (inclusive).

English as a first/primary language.

Adequate sensorimotor function and verbal expressive abilities to complete all assessments.

Must have a co-participant (e.g. spouse, adult child or relative, sibling, cohabitator, friend, caregiver) who has at least weekly in-person contact with the participant and is willing to participate in the study as a collateral informant.

Disqualifiers

Telephone Interview for Cognitive Status (TICS) score of ≤ 22 suggestive of dementia.

Prior diagnosis of Dementia (NIA-AA) or Major Neurocognitive Disorder (DSM-5).

Daily/weekly anticholinergic or sedative use. Stimulants may be allowed pending investigator review.

History of significant or unstable condition/s or treatments for these condition/s that may impact cognition (as determined by the study investigators) such as significant cardiac (e.g. heart failure), infectious (e.g. HIV, urinary tract infection), or metabolic disease (e.g. labile diabetes), cancer (e.g. brain cancer, chemotherapy-induced cognitive impairment), severe mental illness (e.g., bipolar disorder, psychoses), alcohol or substance use disorder, developmental disorder (e.g. autism spectrum disorder, intellectual disability), or other neurologic disease (e.g. movement disorder, multiple sclerosis, moderate to severe brain injury, seizures).

Trial design

Treatments tested in this trial

  • Accelerated iTBS
  • Computerized Cognitive Training
  • Sham Computerized Cognitive Training

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Medical University of South Carolina

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Institute on Aging (NIA)

Collaborator